Why we do medical research
Killer infectious diseases are increasingly difficult to treat due to the rise of antimicrobial resistance. This causes increased hospitalisation and human deaths. In the absence of new drugs, we need alternative approaches to treat infectious diseases caused by superbugs.
How we go about it
We focus on pathogens that hide within our own cells or kill immune cells that are meant to protect us in the first instance. Members of the group lead their own research in a cooperative and professional environment to identify host factors that are hijacked by superbugs.
What we do
We use the latest advances in imaging and genetic screens to discover new molecular and cellular interactions between host immune cells and pathogens. We aim to identify new host targets that will enable us repurpose existing drugs for the treatment of infectious diseases.
in close collaboration with members of the Antimicrobial Resistance Research Group.